Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] media spotlight last week after publication of their paper on the application of CRISPR technology in FSHD cells. In response to the public’s interest in the story, they prepared the following […]
The FSHD Society is holding a landmark meeting today in which individuals and families living with facioscapulohumeral muscular dystrophy (FSHD) will tell representatives from the U.S. Food and Drug Administration […]
[…] years, DUX4 has enjoyed center stage in the yet-unfolding story of facioscapulohumeral muscular dystrophy ( FSHD). DUX4 was first identified in 19991, but only in the past five to 10 […]
[…] 2017 – Today the FSH Society, a world leader in combating facioscapulohumeral muscular dystrophy ( FSHD), announced it has committed $541,133 in funding to five research projects that aim to […]
[…] can evaluate electrical impedance myography (EIM) as a tool for quantifying the muscle structure of FSHD patients. Today, the FSH Society, a Massachusetts based non-profit that is a world leader in […]
